T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
1901
MFA Financial
MFA
$931M
| $772K | ﹤0.01% |
24,357
-5
| -0% | -$165 |
|
1902
Adtran
ADTN
$658M
| $770K | ﹤0.01% |
39,801
-13,110
| -25% | -$291K |
|
1903
Albany International
AIN
$1.82B
| $767K | ﹤0.01% |
12,474
-10
| -0.1% | -$603 |
|
|
EBIX
1904
DELISTED
Ebix Inc
EBIX
| $766K | ﹤0.01% |
9,662
-2,110
| -18% | -$153K |
|
1905
Globus Medical
GMED
$11.5B
| $764K | ﹤0.01% |
18,583
-20
| -0.1% | -$700 |
|
1906
Park Hotels & Resorts
PK
$3.03B
| $764K | ﹤0.01% |
26,590
+1,530
| +6% | +$43.8K |
|
1907
Merit Medical Systems
MMSI
$5.4B
| $761K | ﹤0.01% |
17,622
+450
| +3% | +$18.9K |
|
1908
S&T Bancorp
STBA
$1.82B
| $760K | ﹤0.01% |
19,085
-10
| -0.1% | -$405 |
|
|
SUM
1909
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $759K | ﹤0.01% |
24,540
-21
| -0.1% | -$632 |
|
|
SRC
1910
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $754K | ﹤0.01% |
19,610
-27,863
| -59% | -$1.06M |
|
1911
Strategy Inc
MSTR
$38.2B
| $752K | ﹤0.01% |
57,310
+16,980
| +42% | +$228K |
|
|
SNR
1912
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $751K | ﹤0.01% |
99,380
+34,200
| +52% | +$285K |
|
|
HT
1913
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $749K | ﹤0.01% |
43,064
+2,975
| +7% | +$53.2K |
|
1914
Coherent
COHR
$64B
| $745K | ﹤0.01% |
15,859
-4,110
| -21% | -$185K |
|
1915
Extreme Networks
EXTR
$3.16B
| $742K | ﹤0.01% |
59,300
| – | – |
|
1916
Korn Ferry
KFY
$4.36B
| $738K | ﹤0.01% |
17,834
-10
| -0.1% | -$415 |
|
1917
KBR
KBR
$4.81B
| $735K | ﹤0.01% |
37,069
-8,460
| -19% | -$160K |
|
|
LGF.A
1918
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $734K | ﹤0.01% |
21,717
-40
| -0.2% | -$1.26K |
|
|
BSFT
1919
DELISTED
BroadSoft, Inc.
BSFT
| $734K | ﹤0.01% |
13,376
-10
| -0.1% | -$545 |
|
1920
Old National Bancorp
ONB
$10.4B
| $733K | ﹤0.01% |
41,994
-24
| -0.1% | -$431 |
|
|
AMED
1921
DELISTED
Amedisys
AMED
| $731K | ﹤0.01% |
13,870
-10
| -0.1% | -$527 |
|
1922
Liberty Media Series A
FWONA
$23.7B
| $730K | ﹤0.01% |
23,298
+2,799
| +14% | +$95.7K |
|
|
AMWD
1923
DELISTED
American Woodmark
AMWD
| $727K | ﹤0.01% |
5,579
-1,400
| -20% | -$147K |
|
|
VRE
1924
DELISTED
Veris Residential
VRE
| $726K | ﹤0.01% |
33,671
-7,316
| -18% | -$165K |
|
|
SHLM
1925
DELISTED
Schulman (A.) Inc
SHLM
| $722K | ﹤0.01% |
19,383
-10
| -0.1% | -$372 |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.